FAM
BIO icon

Fred Alger Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fred Alger Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,083
Closed -$261K – 455
2025
Q2 		$261K Buy
1,083
+89
+9% +$21K ﹤0.01% 405
2025
Q1 		$242K Buy
+994
New +$299K ﹤0.01% 405
2020
Q3 		– Sell
-11,612
Closed -$5.24M – 468
2020
Q2 		$5.24M Buy
11,612
+1,986
+21% +$876K 0.02% 224
2020
Q1 		$3.37M Buy
9,626
+2,306
+32% +$848K 0.01% 237
2019
Q4 		$2.71M Buy
7,320
+3,320
+83% +$1.17M 0.01% 275
2019
Q3 		$1.33M Buy
+4,000
New +$1.3M 0.01% 313

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return